Pharmaceutical supply chain security: hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, July 11, 2006, Volume 4
What people are saying - Write a review
We haven't found any reviews in the usual places.
Hearing held on July 11 2006
letters statements etc submitted for the record
Gray John M president and CEO Healthcare Distribution Management
American Pharmacists Association anti-counterfeiting APhA Association authorized distributor Boards of Pharmacy Catizone chain of custody Committee on Government consumers Counterfeit Drug Task counterfeit medications counterfeit pharmaceuticals counterfeit products Delli-Colli distributor of record drug manufacturers Drug Marketing Act Drug Policy drug products drug supply chain Drug Task Force e-pedigree electronic pedigree electronic track enforcement fact-finding effort FDA's federal GlaxoSmithKline Government Reform Gutknecht HDMA identify illegal implementation industry Internet investigations issues item level legitimate licensure Lipitor Lutter medication distribution system NABP NDC number Oxycontin packaging patients PDMA pedigree laws pedigree requirements Pharma pharmaceutical supply chain pharmacists prescription drug Prescription Drug Marketing pseudoephedrine Purdue Pharma Raber Radio Frequency Identification regulations RFID tag risk secondary wholesalers Souder stakeholders standards statement Subcommittee on Criminal Supply Chain Security Task Force Report Thank threat of counterfeit trace technology track and trace U.S. drug supply wholesale distributors widespread adoption